p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
about
Emerging preclinical pharmacological targets for Parkinson's diseaseNeuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β PathwayThe Role of Unfolded Protein Response and Mitogen-Activated Protein Kinase Signaling in Neurodegenerative Diseases with Special Focus on Prion DiseasesERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activationNeurotrophin signalling: novel insights into mechanisms and pathophysiology.Saponins from Panax japonicus attenuate age-related neuroinflammation via regulation of the mitogen-activated protein kinase and nuclear factor kappa B signaling pathways.Meta-analysis of transcriptomic changes in optic nerve injury and neurodegenerative models reveals a fundamental response to injury throughout the central nervous system.Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.Age-dependent regulation of antioxidant genes by p38α MAPK in the liver.Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease
P2860
Q26764724-D922437B-6D7D-464F-9723-27952C62372AQ28390865-F8523D5B-5F05-428A-B252-2B251BC76712Q30234448-729EA2B9-CAB1-4733-A15F-699DE23406DFQ36820322-266B45C3-527C-4D43-A298-6CC6DFEF8641Q37565000-0E3753AF-645E-423C-92A8-ACD514B0BEC0Q37629100-B6B7987D-5EA6-430F-A163-02BCE5002D59Q47155604-EA4E2293-1AEF-4FEF-8C4A-9747D28F834EQ47827985-7740E1F5-072C-4DB5-BBAD-C7DEF8A30B40Q47974836-FE365F14-D689-4325-B4B7-0DBB2A8F6D40Q52649775-6AE06CBD-8D3A-47B6-8A71-48FD8C9B4139Q54981824-4ADB1959-608B-496F-B268-248419E84657Q55093166-2A542087-CABB-4D37-BC18-E503D7AC5240Q55286336-D5E8AD97-4A34-4E84-A9F0-0DEB6ADCAC38Q58708199-09CCC3D1-FCE6-4279-9A24-DBEE27CE8190
P2860
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@ast
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@en
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@nl
type
label
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@ast
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@en
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@nl
prefLabel
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@ast
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@en
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@nl
P2093
P2860
P3181
P1476
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease
@en
P2093
Niraj Kumar Jha
Pravir Kumar
Rashmi K Ambasta
Saurabh Kumar Jha
P2860
P3181
P407
P577
2015-01-01T00:00:00Z